Physician profile
Gregory A Waller
NPI 1023036217
$3,932.35
in general payments reported to CMS, 2019-2025
26 companies · $184 in 2025
The $184 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,077 · 2020: $61.77 · 2021: $478 · 2022: $561 · 2023: $130 · 2024: $1,440 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,416 · Travel and Lodging: $323 · Gift: $14.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,416.42 |
| Travel and Lodging | $322.85 |
| Gift | $14.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,646.52 | 2019-2024 | |
| Abbvie INC. | $372.65 | 2019-2022 | |
| Hologic Sales and Service, LLC | $153.71 | 2019-2025 | Fluent Fluid Management System, Myosure Tissue Removal Device, Novasure |
| Bayer Healthcare Pharmaceuticals INC. | $91.39 | 2019-2023 | |
| Pfizer INC. | $78.79 | 2022-2025 | |
| Baxter Healthcare | $69.53 | 2025 | Perclot |
| Medtronic, INC. | $50.33 | 2021-2024 | Ligasure |
| Organon LLC | $47.39 | 2023-2024 | Nexplanon |
| Therapeuticsmd, INC. | $37.91 | 2019-2021 | |
| Channel Medsystems, INC. | $34.20 | 2023 | |
| Radius Health, INC. | $33.40 | 2024 | Tymlos |
| Scynexis, INC. | $30.08 | 2022 | |
| Meditrina | $29.68 | 2024-2025 | |
| Evofem Biosciences, INC. | $29.60 | 2022 | |
| Coopersurgical, INC. | $28.88 | 2020-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $28.85 | 2025 | Dexcom G6 Transmitter |
| Amgen INC. | $25.61 | 2019 | |
| Duchesnay USA Incorporated | $21.13 | 2019 | |
| Mayne Pharma Commercial LLC | $20.33 | 2023 | |
| Astellas Pharma US INC | $16.78 | 2024 | Veozah |
| Mission Pharmacal Company | $16.16 | 2019 | |
| Minerva Surgical, INC | $15.52 | 2024 | |
| Sumitomo Pharma America, INC. | $15.41 | 2024 | Myfembree |
| Avion Pharmaceuticals | $13.36 | 2022 | |
| Myovant Sciences INC. | $12.72 | 2021 | |
| Coloplast Corp | $12.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Waller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.